Burkitt Lymphoma: Diagnosis, Risk Factors and Treatment

$195.00

Douglas V. Berthelot (Editor)

Series: Cancer Etiology, Diagnosis and Treatments
BISAC: MED062020
DOI: https://doi.org/10.52305/VODC3429

Burkitt lymphoma (BL) is a form of non-Hodgkin’s lymphoma in which cancer starts in immune cells called B-cells. If left untreated, it is rapidly fatal. Chapter One of this monograph evaluates the etiology, pathological issues, diagnosis, clinical manifestations, epidemiology, research, innovation and treatment issues of BL using the clinical systematic review research method and experts’ opinion analysis approach. Chapter Two reviews the spectrum, unique characteristics and special management considerations when BL develops in specific subgroups of patients with primary immune deficiency disorders. Chapter Three reviews the incidence, clinicopathological and epidemiologic features, treatment and outcome data available in pediatric and adult patients with post solid organ transplant BL. Chapter Four focuses on the pathobiology and the treatment of first-line and relapsed/refractory cases of BL and describes new therapeutic strategies which could improve results in this pathology. Chapter Five examines the therapeutic advances in BL and its variants. Finally, Chapter Six explores and emphasizes the trends and issues in research and innovation in the characteristics, clinical updates and management approaches of BL.

Clear

Description

Preface

Chapter 1. Burkitt Lymphoma: Diagnosis and Treatment Issues
(Daniella E.C.C.O.H Kingsley-Godwin, Maria Jana Kingsley Godwin and Joshua Kingsley-Godwin – London Medical Academy, London, England, United Kingdom)

Chapter 2. Burkitt Lymphoma in Patients with Primary Immunodeficiency Disorders
(Zeinab Afify and Oussama Abla – Division of Hematology/Oncology, Department of Pediatrics, University of Utah, Salt Lake City, Utah, US, et al.)

Chapter 3. Post Solid Organ Transplant Burkitt Lymphoma
(Zeinab Afify and Angela Punnett – Department of Pediatrics, University of Utah, Salt Lake City, Utah, US, et al.)

Chapter 4. Burkitt Lymphoma
(Luis M. Juárez-Salcedo, Diego Conde-Royo, and Samir Dalia – Department of Hematology, Gregorio Marañón University Hospital, Madrid, Spain, et al.)

Chapter 5. Examining the Therapeutic Advances for Burkitt Lymphoma
(Daniella E.C.C.O.H Kingsley-Godwin, Maria Jana Kingsley Godwin and Joshua Kingsley-Godwin – London Medical Academy, London, England, United Kingdom)

Chapter 6. Burkitt Lymphoma: Evaluation of Characteristics, Clinical Updates and Management Approaches Trends
(Daniella E.C.C.O.H Kingsley-Godwin, Maria Jana Kingsley Godwin and Joshua Kingsley-Godwin – London Medical Academy, London, England, United Kingdom)

Index

Additional information

Binding

,